CNV-dopamine is a photoactivatable, selective agonist of the D2 receptor (D2 receptor). It activates the D2 receptor, triggering G protein-coupled inwardly rectifying potassium (GIRK) currents. CNV-dopamine shows potential for research in diseases such as Parkinsons disease and addiction.
Target:
Dopamine Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
